Dr. Michael Hartmann

Bis 2017, Director Business Unit Drug Products, DSM Sinochem Pharmaceuticals

Österreich

Fähigkeiten und Kenntnisse

Strategy Development & Implementation
M&S
Innvovation and Business Development
KPI Development & Tracking
R&D
Operations Management (interdisciplinary)
General Mangement
Leading multicultural teams
Business Intelligence
Leading interdisciplinary teams / matrix organizat
Change Management
Restructuring / Reorganizations
Build new organizations from scratch
M&A
Operational Due Diligence
Internationality (Asia/India/US etc.)
Engaging Teams

Werdegang

Berufserfahrung von Michael Hartmann

  • 3 Jahre und 4 Monate, Juli 2014 - Okt. 2017

    Director Business Unit Drug Products

    DSM Sinochem Pharmaceuticals

    Create a new business unit from scratch as future growth driver for the company. - breakdown strategy into clear actions, detailed milestones and goals (Balanced Scorecard, KPI's) - build up of competent (highly diverse) organization to develop, launch and supply the new product pipelines to the customers - establishment of global network with several major suppliers - secure with new pipeline sales of the future - doubling sales year after year

  • 2 Jahre und 11 Monate, Aug. 2011 - Juni 2014

    New Business Development Director

    DSM Sinochem Pharmaceuticals

    Responsibility for all new business initiatives globally. Course-plotting of the growth strategy by portfolio management, local execution teams and clear goals. - clear portfolio management - strong project organization in India, China and Europe formed - successful launch of major cholesterol lowering drug resulted in a project to construct a world class plant in India - successful development of Drug Product Portfolio led to formation of an own Business Unit Drug Products

  • 2 Jahre und 9 Monate, Nov. 2008 - Juli 2011

    SVP New Business Development & Strategy (Pharma & Crop Protection)

    DSM Pharma Chemicals Austria

    Lead new business development and strategy organization to grow the business with new products. - strategy defined and executed to combine contract manufacturing opportunities as base load with highly innovative very profitable growing products - business-technology strategy analysis performed to align customer needs, R&D production and technology profile for future developments - Growth of portfolio resulted into 80M€ new business sales and full pipeline

  • 2 Jahre und 4 Monate, Juli 2006 - Okt. 2008

    SVP Marketing und Sales (Pharma)

    DSM Pharma Chemicals Austria

    esponsible for M&S inEurope and Asia. Build up of strong customer base with a broader product portfolio in a short timeframe and to form a team in the head office in Vienna, while growing the business. - Build up of new M&S team from the Netherlands to Austria - M&S Excellence Program - formation of strong Key Account Management, development and execution of business and account plans - with succesful customer acquisition sales growth of 20 % achieved

  • 3 Jahre und 11 Monate, Aug. 2002 - Juni 2006

    VP Operations (Site Manager Pharma)

    DSM Pharma Chemicals Austria

    Responsible for M&S inEurope and Asia. Build up of strong customer base with a broader product portfolio in a short timeframe and to form a team in the head office in Vienna, while growing the business. - Build up of new M&S team from the Netherlands to Austria - M&S Excellence Program - formation of strong Key Account Management, development and execution of business and account plans - with succesful customer acquisition sales growth of 20 % achieved

  • 5 Jahre und 3 Monate, Mai 1997 - Juli 2002

    R&D Director (Bulk, Speciality chemicals & Pharma Intermediates)

    DSM Fine Chemicals Austria

    R&D development and scale up of new technologies, technology improvements and new products. 3 businesses of company (bulk, speciality chemicals and Pharma Intermediates production) served. - technology strategy for all 3 businesses developed and executed - expertise and quality of staff substantially improved - project and portfolio management implemented - as a result, new products and technology improvments became the major growth driver for all the 3 businesses.

  • 2 Jahre und 1 Monat, Mai 1995 - Mai 1997

    Head of Development Chemistry

    Nycomed Pharma

  • 1 Jahr und 10 Monate, Juli 1993 - Apr. 1995

    Head of Research Chemistry

    Nycomed Pharma

  • 1992 - 1993

    Senior Research Fellow/Group Leader

    Nycomed Hafslund

Ausbildung von Michael Hartmann

  • Bis heute

    University of Texas, Austin

  • Bis heute

    Chemistry

    University of Vienna

  • Bis heute

    Organic chemistry

    University of Vienna

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

Interessen

Hiking
Skiing and Crosscountry Skiing
Music
Fish breeding
Travelling

21 Mio. XING Mitglieder, von A bis Z